The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors BeiGene AUS Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Cancellation by sponsor (1) (-) Cancellation by sponsor (1) Prescription medicine registration (6) Prescription medicine registration (6) Australian Public Assessment Report (AusPAR) (4) Australian Public Assessment Report (AusPAR) (4) Designation or determination (3) Designation or determination (3) Prescription medicine decision summary (3) Prescription medicine decision summary (3) ARTG (2) ARTG (2) Prescription medicine evaluation (2) Prescription medicine evaluation (2) Show more Date 2025 (1) 2025 (1) Search Filters applied:Cancellation by sponsorClear all Sponsor content1 result(s) found, displaying 1 to 1 TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act 24 February 2025 Cancellation by sponsor Requested by Beigene Aus Pty Ltd
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act 24 February 2025 Cancellation by sponsor Requested by Beigene Aus Pty Ltd